Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study
PaperCitations, authors & open-access status
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 385 citations, 2015 year and hybrid oa status.
385
Citations
2015
Year
hybrid
OA Status